Avigan Maker Applies For Government Approval

Avigan maker applies for government approval

A Japanese pharmaceutical company has applied for government approval to use its anti-flu drug Avigan to treat COVID-19 patients.

Fujifilm Toyama Chemical, which is part of the Fujifilm Holdings group of companies, filed the application with Japan's health ministry on Friday.

Avigan Maker: Efficacy Against Covid-19 Confirmed

Avigan maker: Efficacy against COVID-19 confirmed

The developer of the influenza treatment Avigan says the drug's efficacy in treating COVID-19 patients has been confirmed in a clinical trial.

Fujifilm Toyama Chemical, which is part of the Fujifilm Holdings group of companies, developed the drug. In the observational study, Avigan was given to coronavirus patients with mild symptoms.